In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.28 below Tandem Diabetes Care Inc average.

Within Medical Equipment & Supplies industry 85 other companies have achieved higher Quick Ratio than Tandem Diabetes Care Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 657 to 1478.

Explain Quick Ratio?
How much Cash & cash equivalents TNDM�s has?
What are TNDM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TNDM/financial-strength

https://api.csimarket.com/api/v1/companies/TNDM/fundamentals

https://api.csimarket.com/api/v1/companies/TNDM/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

TNDM Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	29.19 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-77.17 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.28	Subscribe	Subscribe	Subscribe	Subscribe
TNDM's Total Ranking	# 1478	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	0.62 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-84.03 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 86
Healthcare Sector	# 519
Overall Market	# 1478

Quick Ratio Statistics
High	Average	Low
42.33	5.88	0.43
(Dec 31 2009)		(Sep 30 2017)

Financial Statements
Tandem Diabetes Care Inc 's Current Liabilities	$ 256 Millions	Visit TNDM's Balance sheet
Tandem Diabetes Care Inc 's Cash & cash equivalent	$ 73 Millions	Visit TNDM's Balance sheet
Source of TNDM's Sales		Visit TNDM's Sales by Geography

Cumulative Tandem Diabetes Care Inc 's Quick Ratio

TNDM's Quick Ratio for the trailling 12 Months

TNDM Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	24.96 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-3.45 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.51	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4052	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	6.68 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-15.03 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to TNDM Financial Strength Comparisons >> Go to Compare TNDM Quick Ratio to its Competitors

News about Tandem Diabetes Care Inc Quick Ratio

Tandem Diabetes Care Prices Upsized Private Placement of $2750 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023

Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029; Quick Ratio Falls in Q4 2023
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 in a private placement. This offering was upsized from the previous amount. The notes were offered to qualified institutional buyers under Rule 144A of the Securities Act of 1933.
In the wake of an increase in Current Liabilities in the fourth quarter of 2023, Tandem Diabetes Care s Quick Ratio fell to 3.49, which is still above the company s average Quick Ratio. It is worth noting that seven other companies within the industry have achieved higher Quick Ratios in the same quarter.

On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2026 to $256.08 millions, cumulative Quick Ratio decreased to 1.51 below the average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Tandem Diabetes Care Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2151 to 4052.

Explain Quick Ratio?
How much Cash & cash equivalents TNDM�s has?
What are TNDM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 206
Healthcare Sector	# 903
Within the Market	# 4052

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.39	1.59	0.21
(Jun 30 2011)		(Mar 31 2025)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Qhslab Inc	0.77	$ 0.190 Millions	$ 0.247 Millions
Livanova Plc	0.76	$ 563.467 Millions	$ 740.193 Millions
West Pharmaceutical Services Inc	0.72	$ 464.100 Millions	$ 644.300 Millions
Resmed Inc	0.72	$ 1,010.742 Millions	$ 1,406.488 Millions
Harvard Apparatus Regenerative Technology Inc	0.70	$ 1.851 Millions	$ 2.647 Millions
Electrocore Inc	0.69	$ 7.506 Millions	$ 10.866 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	0.69	$ 8.124 Millions	$ 11.778 Millions
Sintx Technologies Inc	0.67	$ 2.005 Millions	$ 3.004 Millions
Privia Health Group Inc	0.66	$ 446.283 Millions	$ 674.358 Millions
Lensar Inc	0.64	$ 12.622 Millions	$ 19.811 Millions
Orthofix Medical Inc	0.62	$ 86.322 Millions	$ 138.385 Millions
Carlisle Companies Incorporated	0.62	$ 546.700 Millions	$ 880.300 Millions
Heartflow Inc	0.59	$ 31.649 Millions	$ 53.410 Millions
Align Technology inc	0.57	$ 1,144.931 Millions	$ 2,002.010 Millions
Angiodynamics Inc	0.57	$ 33.973 Millions	$ 59.689 Millions
Co diagnostics Inc	0.57	$ 1.430 Millions	$ 2.512 Millions
Baxter International Inc	0.52	$ 1,976.000 Millions	$ 3,809.000 Millions
Infusystem Holdings Inc	0.51	$ 9.108 Millions	$ 17.873 Millions
Northview Acquisition Corp	0.51	$ 8.400 Millions	$ 16.581 Millions
Stryker Corp	0.50	$ 3,271.000 Millions	$ 6,500.000 Millions
Msa Safety Inc	0.50	$ 187.248 Millions	$ 373.698 Millions
Teleflex Incorporated	0.50	$ 454.065 Millions	$ 917.102 Millions
Sonoma Pharmaceuticals Inc	0.46	$ 4.609 Millions	$ 9.944 Millions
P3 Health Partners Inc	0.46	$ 43.900 Millions	$ 95.593 Millions
Avita Medical Inc	0.46	$ 10.500 Millions	$ 23.037 Millions
Alphatec Holdings Inc	0.44	$ 79.936 Millions	$ 180.767 Millions
Steris Plc	0.44	$ 531.100 Millions	$ 1,207.800 Millions
Sanuwave Health Inc	0.40	$ 6.569 Millions	$ 16.394 Millions
Novocure Limited	0.38	$ 102.738 Millions	$ 270.659 Millions
Plus Therapeutics Inc	0.37	$ 4.871 Millions	$ 13.123 Millions

Date modified: 2026-11-06T12:58:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.